14. Engaging patients to provide a service
Who, why, when and how should UK pharma compliantly engage patients to provide a range of services? We provide clarity in just a few minutes.
21 Syys 20236min
15. Should/could medical education mention medicine?
Rina & Jean discuss why and how medical education could mention medicine - the pros and the cons, mentioning the results of a LinkedIn poll and Case AUTH/3244/9/19.
21 Syys 20235min
13. Can I buy a Dr a coffee?
How should we handle questions like this? Say no (there could be cake involved!!!)? Or say yes? Which questions should we be asking to be helpful, constructive and compliant?
14 Syys 20236min
12. Engaging social media influencers
Pharma feel nervous when engaging social media influencers, even though they can have a phenomenal impact. There's a lot to consider, so Rina & Jean chat through top-line principles so you can start g...
7 Syys 20235min
11. Emails, consent and queries
Rina & Jean discuss why, who, what and how email consent can comply with the ABPI Code.
31 Elo 20238min
10. When does the UK Code apply to Global?
What are the FIVE scenarios for when the UK Code applies to Global? Why is this important?
31 Elo 20238min
9. When the PMCPA say "it would have been helpful..."
Rina and Jean discuss a no breach of the ABPI Code for Teva for how their website was accessed (Case 3641/4/22).
24 Elo 20234min
8. Badly let down by an employee
Rina and Jean discuss a breach of the ABPI Code for AstraZeneca, because of how an employee used LinkedIn (Case 3599/1/22).
17 Elo 20234min
